Ligand validation:6AJN

ACO: ACETYL COENZYME *A

ACO is a Ligand Of Interest in 6AJN designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6AJN_ACO_A_1001	6%	16%	0.319	0.755	0.89	2.91	2	14	3	0	100%	1
6AJN_ACO_B_1001	4%	16%	0.384	0.75	0.86	2.95	2	11	0	0	100%	1
6GTP_ACO_A_201	50%	50%	0.182	0.935	0.81	1.13	1	4	2	0	100%	0.8
6GTR_ACO_A_201	4%	50%	0.392	0.754	0.81	1.13	1	4	2	0	100%	0.7471
3R96_ACO_B_400	99%	54%	0.056	0.985	0.72	1.04	-	3	0	0	100%	1
4B5O_ACO_A_1197	99%	50%	0.065	0.993	1.05	0.87	4	-	0	0	100%	1
5LS7_ACO_B_203	98%	37%	0.059	0.983	1.07	1.48	3	10	0	0	100%	1
3TE4_ACO_A_231	98%	44%	0.059	0.98	0.97	1.25	2	6	0	0	100%	1
4IF5_ACO_A_201	98%	20%	0.064	0.983	2.35	1.19	12	6	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.